Incode and Odyssey Therapeutics each secured over $200m while Alvotech Holdings, BenevolentAI and Tomorrow.io have agreed reverse mergers at unicorn valuations.
Funding
Internet and technology group SoftBank has co-led a $220m series B round for US-headquartered identity verification and authentication software provider Incode with growth equity firm General Atlantic at a $1.25bn valuation. Capital One Ventures and Coinbase Ventures invested on behalf of financial services firm Capital One and digital currency exchange Coinbase, and the round included investment bank JP Morgan, Silicon Valley CISO Investments, DN Capital, 3L Capital, Framework Ventures, Dila Capital and the founders of payment software provider dLocal.
US-based cancer and inflammatory disease drug developer Odyssey Therapeutics has closed a $218m series A round co-led by SR One Capital Management, the venture capital firm backed by pharmaceutical firm GlaxoSmithKline. Healthcare investment firm OrbiMed co-led the round, which included Foresite Capital, Woodline Partners, Logos Capital, HBM Healthcare Investments, Colt Ventures and Creacion Ventures.
Heap, a US-headquartered provider of digital experience analytics software, has completed a $110m series D round…
